No. There is no risk of being short Nanoviricides. There are other reasons to not be short however, such as the high leverage hit one has to take to maintain a short position. If the stock somehow made it to $2.00 per share I would sit there with a million share offer. Until then, I think the price dynamics of sub $2 stocks in the current environment is not appropriate for a short seller, no matter how clear the fraud is (as is the case with NNVC).
News 
Market Data 
Discover 
